Furthermore, some secreted HSGPs, such as syndecan-1 and glypican-1, are increased in a variety of malignancies such as thyroid [29], pancreatic cancer [30, 31], breast cancer and myeloma [32]. This evidence concerns the gene SDC1 and breast carcinoma.